Table 3 Comparison of overall efficacy between the experimental group and the control group in HR+/HER-2 negative patients (%).
Number | CR | PR | SD | PD | ORR | DCR | PCR | |
|---|---|---|---|---|---|---|---|---|
Experimental group | 30 | 14(47) | 16(53) | 0(0) | 0(0) | 30(100) | 30(100) | 14(47) |
Control group | 30 | 4(13) | 21(70) | 2(7) | 3(10) | 25(83) | 27(90) | 4(13) |
χ2-value | 7.933 | 1.763 | 2.069 | 3.158 | 5.455 | 3.158 | 7.937 | |
P-value | 0.005 | 0.184 | 0.150 | 0.076 | 0.020 | 0.076 | 0.005 |
